Literature DB >> 19120651

A novel finding that Streptomyces clavuligerus can produce the antibiotic clavulanic acid using olive oil as a sole carbon source.

G Efthimiou1, A E Thumser, C A Avignone-Rossa.   

Abstract

AIMS: This study aims to establish whether commercially available food oils can be used by Streptomyces clavuligerus as sole carbon sources for growth and clavulanic acid production. METHODS AND
RESULTS: Batch cultures in bioreactors showed that Strep. clavuligerus growth and clavulanic acid yields in a P-limited medium containing 0.6% (v/v) olive oil were respectively 2.5- and 2.6-fold higher than in a glycerol-containing medium used as control. Glycerol- and olive oil-grown cells present different macromolecular composition, particularly lipid and protein content.
CONCLUSIONS: Streptomyces clavuligerus uses olive oil as the sole carbon and energy source for growth and clavulanic acid production. Yields and production rates in olive oil are comparable to those reported for oil-containing complex media. Differences in yields and in the macromolecular composition indicate that different metabolic pathways convert substrate into product. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report of oils being used as the sole carbon source by Strep. clavuligerus. Apart from economic benefits, interesting questions are raised about Strep. clavuligerus physiology. Defined culture media allow physiological studies to be performed in the absence of interference by other compounds. Understanding how Strep. clavuligerus catabolises oils may have an economic impact in clavulanic acid production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120651     DOI: 10.1111/j.1365-2672.2008.03975.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  5 in total

1.  Enhanced Triacylglycerol Metabolism Contributes to Efficient Oil Utilization and High-Level Production of Salinomycin in Streptomyces albus ZD11.

Authors:  Han Li; Jiaxiu Wei; Jianxin Dong; Yudong Li; Yongquan Li; Yinghu Chen; Wenjun Guan
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

2.  Screening of wild type Streptomyces isolates able to overproduce clavulanic acid.

Authors:  Daniela A Viana Marques; Valéria de Carvalho Santos-Ebinuma; Patrícia Maria Sobral de Oliveira; Gláucia Manoella de Souza Lima; Janete M Araújo; José L Lima-Filho; Attilio Converti; Adalberto Pessoa-Júnior; Ana L F Porto
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

Review 3.  Fermentation Conditions that Affect Clavulanic Acid Production in Streptomyces clavuligerus: A Systematic Review.

Authors:  Hooi-Leng Ser; Jodi Woan-Fei Law; Nathorn Chaiyakunapruk; Sabrina Anne Jacob; Uma Devi Palanisamy; Kok-Gan Chan; Bey-Hing Goh; Learn-Han Lee
Journal:  Front Microbiol       Date:  2016-04-22       Impact factor: 5.640

Review 4.  Active pharmaceutical ingredient (API) chemicals: a critical review of current biotechnological approaches.

Authors:  Vinod Kumar; Vasudha Bansal; Aravind Madhavan; Manoj Kumar; Raveendran Sindhu; Mukesh Kumar Awasthi; Parameswaran Binod; Saurabh Saran
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 5.  Production of β-Lactamase Inhibitors by Streptomyces Species.

Authors:  Daniela de Araújo Viana Marques; Suellen Emilliany Feitosa Machado; Valéria Carvalho Santos Ebinuma; Carolina de Albuquerque Lima Duarte; Attilio Converti; Ana Lúcia Figueiredo Porto
Journal:  Antibiotics (Basel)       Date:  2018-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.